According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -$12.08. In 2022 the company made an earnings per share (EPS) of -$4.48 a decrease over its 2021 EPS that were of $4.33.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$12.08 | 169.64% |
2022 | -$4.48 | -203.46% |
2021 | $4.33 | -25.09% |
2020 | $5.78 | 445.28% |
2019 | $1.06 | -15.2% |
2018 | $1.25 | -35.9% |
2017 | $1.95 | 69.57% |
2016 | $1.15 | -27.67% |
2015 | $1.59 | 65.63% |
2014 | $0.96 | 11.63% |
2013 | $0.86 | 32.31% |
2012 | $0.65 | 1.56% |
2011 | $0.64 | -60.74% |
2010 | $1.63 | 59.8% |
2009 | $1.02 | 47.83% |
2008 | $0.69 | -12.66% |
2007 | $0.79 | -35.77% |
2006 | $1.23 | 59.76% |
2005 | $0.77 | 26.21% |
2004 | $0.61 |